Skip to product information
NAD+ 5 Peptide Strips | StripBox 2a

NAD+ | 5ct Peptide Strips

For research use only. Not for human consumption. Compassionate curators of fine peptides.

NAD+ · 100 mg per strip

Mollecule NAD+ features one of biology's most essential cellular coenzymes, making it a cornerstone of metabolic and mitochondrial research. Produced in a state-of-the-art manufacturing environment, every batch undergoes comprehensive third-party laboratory testing to confirm purity and quality. Backed by a Certificate of Analysis (COA), Mollecule NAD+ reflects our commitment to delivering research compounds that meet the highest standards of precision and consistency.

Pack
5ct Peptide Strips

Strip protocol

Ready-to-use films. No reconstitution.

  1. Keep sealed

    Leave films in the foil pouch at room temperature, away from moisture.

  2. Use dry hands

    Peel one film when needed. It dissolves on liquid contact in 30 to 60 seconds.

  3. Record the lot

    Note the lot number in your lab records.

Related peptides

Sources & References

Peer-reviewed research

  • NEW ENGLAND JOURNAL OF MEDICINE

    Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial

    2023 DOI: 10.1056/NEJMoa2301972 Jastreboff AM, et al.

    View Source
  • THE LANCET

    GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial

    2023 Rosenstock J, et al.

    View Source
  • NATURE MEDICINE

    GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease

    2024 Sanyal AJ, et al.

    View Source
  • LANCET DIABETES & ENDOCRINOLOGY

    Effects of GLP-3 (RT) on Body Composition

    2025 Coskun T, et al.

    View Source
  • PUBMED CENTRAL

    Triple Agonism Based Therapies for Obesity

    2025

    View Source
  • PUBMED CENTRAL

    GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy

    2025

    View Source
  • PUBMED CENTRAL

    Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis

    2024

    View Source
  • NATURE CELL DISCOVERY

    Structural Analysis of Incretin Receptor Agonists

    2024

    View Source